Description: Scopus BioPharma Inc. develops therapeutics drugs targeting the endocannabinoid system. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December, 2017. The company was incorporated in 2017 and is based in New York, New York.
Home Page: scopusbiopharma.com
SCPS Technical Analysis
420 Lexington Avenue
New York,
NY
10170
United States
Phone:
212 479 2513
Officers
| Name | Title |
|---|---|
| Mr. Robert J. Gibson | Vice Chairman, Sec. & Treasurer |
| Mr. Ira Scott Greenspan | Sr. Advisor & Director |
| Mr. David Silberg | Sr. Advisor |
| Dr. Alan D. Horsager Ph.D. | Pres?of?Immuno-Oncology and Pres & CEO of Duet BioTherapeutics |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.4153 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-12-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 9 |